Epidemiology of Acute Childhood Leukemia

Julie A. Ross, Kimberly J. Johnson, Logan G. Spector, John H. Kersey

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Approximately 10,700 children under the age of 15 years are newly diagnosed with cancer each year in the United States (American Cancer Society, 2008), including nearly 3,500 children with leukemia. Even with great advances in treatment over the last several decades, leukemia remains a major source of disease-related morbidity and mortality in children. Of the leukemias, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), comprise the vast majority in childhood, occurring at a frequency of approximately 76% and 18%, respectively (Ries et al. 1999). Other leukemias can occur in children, but are extremely rare, including biphenotypic or mixed lineage leukemia, chronic myelogenous leukemia (CML), juvenile myelomonocytic leukemia (JMML), and chronic lymphocytic leukemia (CLL). This review focuses on the epidemiology of childhood ALL and AML. Below, we provide an overview of the classification systems used, including how these entities may help define the timing of when the leukemia might have occurred. Second, international and national data with regard to incidence and survival rates, along with trends, are described. Further, risk factors associated with childhood leukemia are discussed including inherited syndromes, exposures and conditions, and genetic susceptibility as measured through single nucleotide polymorphisms (SNPs). Finally, we discuss challenges and potential future directions that may lead to more fruitful understanding of the underlying causes of childhood leukemia.
Original languageEnglish (US)
Title of host publicationChildhood Leukemia
Subtitle of host publicationA Practical Handbook
DOIs
StatePublished - 2011

Fingerprint

Leukemia
Epidemiology
Acute Myeloid Leukemia
Juvenile Myelomonocytic Leukemia
Child Mortality
B-Cell Chronic Lymphocytic Leukemia
Genetic Predisposition to Disease
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Single Nucleotide Polymorphism
Survival Rate
Morbidity
Incidence
Neoplasms

Cite this

Ross, J. A., Johnson, K. J., Spector, L. G., & Kersey, J. H. (2011). Epidemiology of Acute Childhood Leukemia. In Childhood Leukemia : A Practical Handbook https://doi.org/10.1007/978-3-642-13781-5_1

Epidemiology of Acute Childhood Leukemia. / Ross, Julie A.; Johnson, Kimberly J.; Spector, Logan G.; Kersey, John H.

Childhood Leukemia : A Practical Handbook. 2011.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ross, JA, Johnson, KJ, Spector, LG & Kersey, JH 2011, Epidemiology of Acute Childhood Leukemia. in Childhood Leukemia : A Practical Handbook. https://doi.org/10.1007/978-3-642-13781-5_1
Ross JA, Johnson KJ, Spector LG, Kersey JH. Epidemiology of Acute Childhood Leukemia. In Childhood Leukemia : A Practical Handbook. 2011 https://doi.org/10.1007/978-3-642-13781-5_1
Ross, Julie A. ; Johnson, Kimberly J. ; Spector, Logan G. ; Kersey, John H. / Epidemiology of Acute Childhood Leukemia. Childhood Leukemia : A Practical Handbook. 2011.
@inbook{f5a25fe9daa04ba8b541769be53af695,
title = "Epidemiology of Acute Childhood Leukemia",
abstract = "Approximately 10,700 children under the age of 15 years are newly diagnosed with cancer each year in the United States (American Cancer Society, 2008), including nearly 3,500 children with leukemia. Even with great advances in treatment over the last several decades, leukemia remains a major source of disease-related morbidity and mortality in children. Of the leukemias, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), comprise the vast majority in childhood, occurring at a frequency of approximately 76{\%} and 18{\%}, respectively (Ries et al. 1999). Other leukemias can occur in children, but are extremely rare, including biphenotypic or mixed lineage leukemia, chronic myelogenous leukemia (CML), juvenile myelomonocytic leukemia (JMML), and chronic lymphocytic leukemia (CLL). This review focuses on the epidemiology of childhood ALL and AML. Below, we provide an overview of the classification systems used, including how these entities may help define the timing of when the leukemia might have occurred. Second, international and national data with regard to incidence and survival rates, along with trends, are described. Further, risk factors associated with childhood leukemia are discussed including inherited syndromes, exposures and conditions, and genetic susceptibility as measured through single nucleotide polymorphisms (SNPs). Finally, we discuss challenges and potential future directions that may lead to more fruitful understanding of the underlying causes of childhood leukemia.",
author = "Ross, {Julie A.} and Johnson, {Kimberly J.} and Spector, {Logan G.} and Kersey, {John H.}",
year = "2011",
doi = "10.1007/978-3-642-13781-5_1",
language = "English (US)",
booktitle = "Childhood Leukemia",

}

TY - CHAP

T1 - Epidemiology of Acute Childhood Leukemia

AU - Ross, Julie A.

AU - Johnson, Kimberly J.

AU - Spector, Logan G.

AU - Kersey, John H.

PY - 2011

Y1 - 2011

N2 - Approximately 10,700 children under the age of 15 years are newly diagnosed with cancer each year in the United States (American Cancer Society, 2008), including nearly 3,500 children with leukemia. Even with great advances in treatment over the last several decades, leukemia remains a major source of disease-related morbidity and mortality in children. Of the leukemias, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), comprise the vast majority in childhood, occurring at a frequency of approximately 76% and 18%, respectively (Ries et al. 1999). Other leukemias can occur in children, but are extremely rare, including biphenotypic or mixed lineage leukemia, chronic myelogenous leukemia (CML), juvenile myelomonocytic leukemia (JMML), and chronic lymphocytic leukemia (CLL). This review focuses on the epidemiology of childhood ALL and AML. Below, we provide an overview of the classification systems used, including how these entities may help define the timing of when the leukemia might have occurred. Second, international and national data with regard to incidence and survival rates, along with trends, are described. Further, risk factors associated with childhood leukemia are discussed including inherited syndromes, exposures and conditions, and genetic susceptibility as measured through single nucleotide polymorphisms (SNPs). Finally, we discuss challenges and potential future directions that may lead to more fruitful understanding of the underlying causes of childhood leukemia.

AB - Approximately 10,700 children under the age of 15 years are newly diagnosed with cancer each year in the United States (American Cancer Society, 2008), including nearly 3,500 children with leukemia. Even with great advances in treatment over the last several decades, leukemia remains a major source of disease-related morbidity and mortality in children. Of the leukemias, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), comprise the vast majority in childhood, occurring at a frequency of approximately 76% and 18%, respectively (Ries et al. 1999). Other leukemias can occur in children, but are extremely rare, including biphenotypic or mixed lineage leukemia, chronic myelogenous leukemia (CML), juvenile myelomonocytic leukemia (JMML), and chronic lymphocytic leukemia (CLL). This review focuses on the epidemiology of childhood ALL and AML. Below, we provide an overview of the classification systems used, including how these entities may help define the timing of when the leukemia might have occurred. Second, international and national data with regard to incidence and survival rates, along with trends, are described. Further, risk factors associated with childhood leukemia are discussed including inherited syndromes, exposures and conditions, and genetic susceptibility as measured through single nucleotide polymorphisms (SNPs). Finally, we discuss challenges and potential future directions that may lead to more fruitful understanding of the underlying causes of childhood leukemia.

U2 - 10.1007/978-3-642-13781-5_1

DO - 10.1007/978-3-642-13781-5_1

M3 - Chapter

BT - Childhood Leukemia

ER -